
Guardant Health GH
€ 114.02
0.55%
Quartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Guardant Health EV/EBITDA 2011-2026 | GH
EV/EBITDA Jährlich Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38.2 | -17.3 | -5.74 | -8 | -28.8 | -63.4 | -102 | -12.5 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -5.74 | -102 | -34.5 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
-0.68 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 201.41 | -0.81 % | $ 22.4 B | ||
|
Celcuity
CELC
|
-32.4 | $ 87.87 | -0.77 % | $ 4.11 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 4.05 | -5.71 % | $ 5.39 M | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 18.82 | 0.74 % | $ 579 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 20.98 | 1.35 % | $ 608 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.64 | 2.19 % | $ 7.26 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 23.83 | 3.74 % | $ 1.27 B | ||
|
Illumina
ILMN
|
22.1 | $ 166.13 | 3.21 % | $ 25.8 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
20 | $ 147.98 | 1.23 % | $ 11.6 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 161.11 | 2.62 % | $ 23.9 B | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.21 | 0.54 % | $ 1.44 B | ||
|
National Research Corporation
NRC
|
14.3 | $ 18.77 | -0.11 % | $ 420 M | ||
|
Natera
NTRA
|
-112 | $ 216.16 | 1.93 % | $ 29.6 B | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 104.54 | 0.02 % | $ 7.06 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 190.24 | 1.46 % | $ 9.43 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-2.24 | $ 1.39 | 5.81 % | $ 417 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 468.22 | 0.19 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 4.32 | -0.23 % | $ 400 M | ||
|
Personalis
PSNL
|
-4.87 | $ 10.25 | 6.88 % | $ 915 M | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.74 | 1.06 % | $ 25.4 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 7.31 | 1.74 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 81.92 | 7.55 % | $ 4.9 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.01 | -1.95 % | $ 4.62 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 264.57 | -0.6 % | $ 22 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 474.8 | 1.26 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.67 | 2.52 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.22 | 1.26 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M |